-
August 20, 2021 Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction“Cigarette smoking remains one of the most difficult addictions to treat and contributes to more...
-
August 19, 2021 Field Trip Health Expands Access to Ketamine-Assisted PsychotherapyAlthough based in Canada, the company is building a clinical network of therapists trained in...
-
August 18, 2021 Revive Therapeutics Is Exploring This Mushroom’s Potential to Treat Aggressive Breast CancerThe company is also pursuing psilocybin as a possible treatment for rare cancers, but they...
-
August 17, 2021 Canada Green Lights Country’s Third Clinical Psilocybin StudyThe trial will build on Diamond Therapeutic's previous animal research that demonstrated how non-hallucinogenic doses...
-
August 16, 2021 Beckley Psytech Raises $80 Million to Fund Psychedelic Research PipelineThe company will use proceeds of the fundraising round to complete its ongoing Phase 1B...
-
August 12, 2021 Nova Mentis Reaches Milestone Developing Psilocybin to Treat AutismNova Mentis says that psilocybin could be a novel, first-in-class treatment for a brain disorder...
-
August 11, 2021 Wesana Health Launches Animal Studies for Psilocybin and TBIAccording to the CDC, about 166 Americans die from TBI-related conditions each day.
-
August 10, 2021 5 Ways Psychedelics Can Help Humanity with Medicinal Benefits You Never ImaginedDMT treating eye disease? Psilocybin reducing obesity? The benefits of psychedelics could be truly far...
-
August 9, 2021 Contract Research Organizations Partner to Accelerate European Psychedelic Clinical TrialsA partnership between Clerkenwell Health and Transpharmation provides drug developers a one-stop-shop for all stages...
-
August 6, 2021 Filament Health Patents Extraction Technique for Superior, Cheaper Natural PsilocybinThe Vancouver-based company says it has overcome the challenges of natural extraction with its new...
